US Stocks
/
Opus Genetics, Inc. Share Price
Opus Genetics, Inc. Share Price

Opus Genetics, Inc. Share Price

NASDAQ: IRD | Micro Cap
$4.65
+$0.19 (4.26%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Opus Genetics, Inc. Stock Performance

Open
$4.46
Prev. Close
$4.46
Circuit Range
N/A
Day Range
$4.46 - $4.74
Year Range
$1.70 - $7.05
Volume
1,17,435
Average Traded
$4.65

Opus Genetics, Inc. Share Price Today

As of 10 October 2026, Opus Genetics, Inc.'s share price is $4.65. The stock opened at $4.46, compared to its previous close of $4.46. During today's trading session, Opus Genetics, Inc.'s share price traded between $4.46 and $4.74, with an average price of $4.60. Over the past 52 weeks, the stock has recorded a high of $7.05 and a low of $1.70. In terms of performance, Opus Genetics, Inc.'s share price has declined by 8.82% over the last six months and is up 103.50% on a year-on-year basis.

Opus Genetics, Inc. Share Price Chart

$4.46$4.74
L
Show Current Price
H

Opus Genetics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$289.33M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.29
Revenue (TTM)
$14.20B
Return On Equity (TTM)
828.66%
Profit Margin
-349.23%
Debt to Equity
-2.69
Quarterly Earnings Growth YoY
53.58%

Opus Genetics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$3.08$3.87$2.16$0.76
Net Profit-$17.45-$16.52-$65.54-$8.10
Net Profit Margin-566.56%-426.87%-3034.26%-1065.79%
Income ChangeN/A5.33%-296.73%87.64%

Opus Genetics, Inc. Annual Profit & Loss

All figures in USD

Particulars20242025
Revenue$10.99$14.20
Net Profit-$57.53-$49.59
Net Profit Margin-523.48%-349.23%
Income ChangeN/A13.80%

About Opus Genetics, Inc.

Opus Genetics Inc is a clinical-stage ophthalmic biopharmaceutical company developing therapies to treat patients with inherited retinal diseases (IRDs) and therapies to treat patients with other retinal and refractive disorders. The pipeline includes seven adeno-associated virus (AAV)-based programs, led by OPGx-LCA5 for LCA5-related mutations and OPGx-BEST1 for BEST1-related retinal degeneration, with additional candidates targeting RHO, CNGB1, RDH12, NMNAT1, and MERTK. The company operates in one operating segment, which is the business of developing products related to vision performance and health.

Opus Genetics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$4.82
$4.64
-4.33%
Sep 2026
$3.68
$4.86
+25.94%
Aug 2026
$3.60
$3.85
+3.91%
Jul 2026
$4.05
$3.71
-9.95%
Jun 2026
$4.44
$4.12
-5.50%
May 2026
$5.15
$4.36
-14.51%
Apr 2026
$4.66
$5.10
+12.09%
Mar 2026
$4.04
$4.55
+9.37%
Feb 2026
$2.33
$4.16
+81.26%
Jan 2026
$2.27
$2.29
+14.46%
Dec 2025
$2.08
$2.00
-4.98%
Nov 2025
$2.33
$2.11
-7.66%

IRD Share Price FAQs

What is Opus Genetics, Inc. share price today?

chevron-up
Opus Genetics, Inc. share price today is $4.65 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Opus Genetics, Inc. stock?

chevron-up
The 52 week high of Opus Genetics, Inc. stock is $7.05, while the 52 week low is $1.70 as of 10 Oct '26.

What is IRD's market capitalisation today?

chevron-up
IRD market capitalisation is $289.33M as of October 10, 2026, at 5:18 am IST.

What is IRD's net income for the last quarter?

chevron-up
IRD's net income for the last quarter is -8.10B USD.

What is the 5 year returns of IRD?

chevron-up
The 5 year returns of IRD is 18.02% as on 10 Oct '26.

What is the high & low stock price of IRD today?

chevron-up
IRD stock price hit a high of $4.74 and low of $4.46 as of 10 Oct '26.

Can I buy IRD shares in India?

chevron-up
Yes. You can buy IRD in India by opening an international trading account.